Rhythm Pharmaceuticals, Inc. (RYTM) Revenue History
Rhythm Pharmaceuticals, Inc. (RYTM) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | $3.15M |
| 2022-12-31 | $23.64M |
| 2023-12-31 | $77.43M |
| 2024-12-31 | $130.13M |
| 2025-12-31 | $189.76M |
How RYTM compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| AXGN | Axogen Inc. | $225.21M |
| VNDA | Vanda Pharmaceuticals Inc. | $216.10M |
| SNDX | Syndax Pharmaceuticals Inc. | $172.35M |
| HRTX | Heron Therapeutics Inc. | $154.90M |
| STIM | Neuronetics Inc. | $149.16M |
These are five companies in the same sector as RYTM with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rhythm Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("RYTM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RYTM | $116.27 | +0.69% | 0.15M |
| 3 | ||||
| 4 | ||||
| 5 |